NewsRoom Articles - Page 146 of 154 - PsychedelicNewsWire (PNW)

WednesdayAug 08, 2018 9:00 am

Specific Therapeutic Benefits of Cannabidiol (CBD) Validated by FDA

PsychedelicNewsWire Editorial Coverage: In a landmark announcement, the U.S. Food and Drug Administration (FDA) recently approved a drug derived from pure cannabidiol (CBD), Epidiolex, to treat seizures associated with certain forms of severe epilepsy, setting the stage for huge changes in the world of cannabidiol (CBD). FDA approval of a cannabis-based drug represents seismic political, legal and economic shifts Approval likely will lead to more clinical research and further validation of CBD therapeutic efficacy CBD market projected to explode to more than $2 billion in two years with 39 percent CAGR What’s most transformative about this drug approval is that…

ThursdayAug 02, 2018 12:11 pm

Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) is “One to Watch”

Publicly traded on the Canadian Securities Exchange (CSE.VIDA) and recently graduated to the OTCQX Best Market in the USA (OTCQX.PHVAF) Strong balance sheet and capital structure with over CAD $15.5 million cash, no debt, with less than 60 million shares outstanding – fully capitalized for global distribution Expert management team includes former senior executives from Red Bull, Proctor & Gamble, Labatt’s, Stoli Group and the former CEO of Seagram’s International Joint venture with top Canadian licensed producer WeedMD (TSX: WMD) for one of the first federally legal cannabis beverage manufacturing facility, new global distribution partners Developing best-in-class premium CBD-hemp oil…

MondayJul 30, 2018 1:33 pm

Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) Signs Cannabis Extraction Deal with Cannabis Strategic Ventures (OTC: NUGS)

Sunniva’s CP Logistics to produce ultra-purified extracts under Cannabis Strategic Ventures’ Pure Organix™ brand Investment banking firm Canaccord Genuity initiates coverage of Sunniva Canaccord Genuity gives Sunniva positive share price valuation above current market performance and a “speculative buy” rating Vertically integrated cannabis company Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) has announced an agreement to produce top-quality cannabis extracts for Cannabis Strategic Ventures, Inc. (OTC: NUGS) (http://cnw.fm/B3aVh). Under the white label services agreement, Sunniva’s CP Logistics (“CPL”) subsidiary will produce ultra-purified cannabis extracts for the Pure Organix™ brand, owned by Cannabis Strategic’s subsidiary, Pure Applied Sciences, Inc. From its Sun-Oil Facility in Cathedral…

WednesdayJul 25, 2018 9:00 am

Proposed Legal Changes Offer a Boost for Cannabidiol Companies in the United States

PsychedelicNewsWire Editorial Coverage: Recent growth in the market for cannabidiol (CBD) products has been strong and appears poised to continue. CBD is an active ingredient derived from industrial hemp that does not contain the psychoactive or “high” effect of marijuana. CBD is used in a wide range of products, from cosmetics to pet supplements. The recent acceptance of a CBD-based medicine by U.S. authorities creates potential for legal change that could make the sale of CBD easier. Attention in the mainstream press has created a measure of gravitas for CBD. Marijuana Company of America Inc. (OTC: MCOA) (MCOA Profile) has…

TuesdayJul 24, 2018 1:58 pm

Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) DehydraTECH™ Applicable to Multiple Industries

Active investigation phase in the EU, Canada, China, Japan and India Forming four new wholly owned subsidiaries Seeks to acquire an equitable tax treatment Cannabinoids are poorly absorbed by the body’s gastrointestinal tract, a trait that Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) lipophilic enhancement technology DehydraTECH™ is changing. Previously, consumers have turned to cannabis smoking to achieve higher effectiveness. However, human clinical studies have shown DehydraTECH™ to have a quick rate of absorption, allowing users to avoid the risks associated with smoking. DehydraTECH™ offers improved taste and smell, with effects felt within 15 to 20 minutes as opposed to…

WednesdayJul 18, 2018 9:00 am

Hemp CBD Products Offer a Natural Alternative to Synthetic-Derived Medicines

PsychedelicNewsWire Editorial Coverage: The opioid crisis in North America has drawn attention to the urgent need for alternative medicines, and hemp CBD products offer a viable plant-based option. An active ingredient in industrial hemp, Cannabidiol (CBD) can be extracted to be used in a number of different products such as topicals, tinctures, and capsules. The World Health Organization (WHO) has found CBD to be nonpsychoactive, nonaddictive, and to have a positive effect on patients’ health. Scientific studies have shown CBD to be effective in pain relief and, therefore, it may be a healthier alternative to addictive opioids. Marijuana Company of…

FridayJun 29, 2018 12:52 pm

Marijuana Company of America, Inc. (MCOA) Launches CBD Infused Facial Moisturizer through hempSMART™ Subsidiary

MCOA focusing on non-psychoactive hemp cultivation and product markets Hemp industry’s predicted five-year CAGR of 25 percent expected to take it to $2.6 billion by 2022 hempSMART Face marks subsidiary’s extension into cosmetic products arena Progressive trends in the adoption of hemp-derived products continue to boost the prospects of Marijuana Company of America, Inc. (OTC: MCOA) and its hempSMART™ brand, which announced on June 19 the rollout of its latest cannabidiol-derived cosmetic product for people seeking an all-natural botanical moisturizer. The hempSMART™ Face product marks Marijuana Company of America’s expansion of its hempSMART™ brand into the cosmetic products space, building…

WednesdayJun 27, 2018 9:00 am

Farm Bill Legislation May Springboard Federal Hemp Acceptance

PsychedelicNewsWire Editorial Coverage: The United States House passed the 2018 Farm Bill, which will redefine subsidies to farmers, nutritional welfare recipients, conservationists and others. Tucked into this bill of more than 1,000 pages is hemp legalization legislation supported by Senate Majority Leader Mitch McConnell. Demand – and thus farming revenue – for tobacco is waning, and McConnell says hemp farming could help bolster farming communities in his home state of Kentucky and across the country. Currently listed as a controlled substance under federal law, the new bill will declassify hemp as a schedule 1 drug and label it as a…

FridayJun 22, 2018 12:54 pm

Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Notes Rising Interest in Economic Potential of Industrial Hemp

U.S. legislation to legalize industrial hemp makes significant headway in Congress Non-psychoactive cannabidiol (“CBD”) extracted from industrial hemp expected to become a $1 billion market by 2020 Industrial hemp increasingly seen as an economic boon for farmers seeking alternative agricultural revenue sources Cash Crop Today Investor and Business Resource Summit delivers successful launch during U.S. Hemp History Week Global Hemp Group Inc. (CSE: GHG) (OTC: GBHPF) (FRANKFURT: GHG) has a vision when it comes to industrial hemp – “One world, one plant.” This seemingly simple statement about an ancient plant with so many beneficial uses is ringing true to investors,…

FridayJun 15, 2018 12:22 pm

Marijuana Company of America, Inc. (MCOA) Relaunches Improved hempSMART™ Brain Formulation

Significant changes within politics paint a promising picture for the cannabinoid industry MCOA is involved in the cultivation, manufacture and distribution of hemp-derived products MCOA recently announced the launch of its reformulated, patent pending product, hempSMART™ Brain President Trump recently made the statement that he is likely to back the States Act introduced by Senators Cory Gardner (R-CO) and Elizabeth Warren (D-MA), which removes federal involvement into state-by-state medical and recreational cannabis legislation. This is great news for those in the U.S. cannabinoid market (http://cnw.fm/M4klw). Also, significant changes have taken place in the political acceptance of the cultivation of hemp on…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000